Your Cells Run a Power Plant. Here’s How It Breaks.

Energy Metabolism
Mitochondria
Your body contains roughly 37 trillion cells. Almost every one of them contains hundreds to thousands of mitochondria — organelles that evolved from bacteria two billion years ago and never left. Their job is simple in description and staggering i…
Author

Yannick Loth

Published

June 18, 2026

Your body contains roughly 37 trillion cells. Almost every one of them contains hundreds to thousands of mitochondria — organelles that evolved from bacteria two billion years ago and never left. Their job is simple in description and staggering in scale: convert food and oxygen into ATP, the molecule that powers everything else.

A healthy human recycles approximately 50 kg of ATP per day. Not produces — recycles. The total pool of ATP in the body at any moment is only about 50 grams. That pool turns over roughly a thousand times daily. Every heartbeat, every thought, every immune response, every muscle contraction draws from the same account and replenishes it in real time.

When that recycling machinery slows down, the account balance drops. Not dramatically — not zero, not cardiac arrest. Just 30% less. Maybe 50% less. Enough that everything still works, slowly, painfully, with a recovery time measured in days instead of minutes. That is the metabolic state of ME/CFS.


1 The assembly line

Energy production is a sequential process with three stages, each feeding the next.

Glycolysis happens in the cytoplasm, outside the mitochondria. One molecule of glucose is split into two molecules of pyruvate, yielding 2 ATP. This is fast, doesn’t require oxygen, and is the fallback when everything else fails. It’s also inefficient — 2 ATP from a molecule that could yield 36.

The Krebs cycle (citric acid cycle) runs inside the mitochondrial matrix. Pyruvate enters the mitochondria, is converted to acetyl-CoA by the pyruvate dehydrogenase (PDH) complex, and feeds into an eight-step cycle that strips electrons from carbon bonds and loads them onto carrier molecules (NADH and FADH2). The carbon exits as CO2 — the same CO2 you exhale. The cycle itself produces only 2 ATP directly. Its real output is the loaded electron carriers.

The electron transport chain (ETC) is where the electrons pay off. NADH and FADH2 deliver their electrons to a series of protein complexes (I through IV) embedded in the inner mitochondrial membrane. As electrons pass down the chain, the complexes pump hydrogen ions across the membrane, building an electrochemical gradient. That gradient drives ATP synthase — a literal rotary motor, the smallest engine in biology — which spins and assembles ATP from ADP and phosphate. This stage produces approximately 34 ATP per glucose molecule. It requires oxygen as the final electron acceptor.

In total: 2 (glycolysis) + 2 (Krebs) + ~34 (ETC) = ~38 ATP per glucose. The assembly line is elegant, powerful, and utterly dependent on every stage functioning correctly.


2 Where it breaks in ME/CFS

The evidence for mitochondrial dysfunction in ME/CFS is no longer circumstantial. It comes from multiple independent lines of investigation.

The PDH bottleneck. Fluge, Mella, and colleagues at Haukeland University Hospital reported that ME/CFS patients show evidence of impaired pyruvate dehydrogenase function — the enzyme complex that converts pyruvate to acetyl-CoA, the gateway from glycolysis to the Krebs cycle (Fluge et al. 2016). When PDH is inhibited, pyruvate can’t enter the mitochondria efficiently. It backs up and is converted to lactate instead. The cell falls back on glycolysis — 2 ATP instead of 38. The same glucose, a twentieth of the energy.

The metabolic shift. Metabolomics studies consistently show that ME/CFS patients have altered amino acid profiles, disrupted lipid metabolism, and patterns consistent with impaired mitochondrial fatty acid oxidation (Germain et al. 2017; Naviaux et al. 2016). The picture is one of metabolic inflexibility: the machinery for burning fat (beta-oxidation) and for running the full Krebs cycle is underperforming, forcing greater reliance on the inefficient glycolytic pathway.

The CPET evidence. Two-day cardiopulmonary exercise testing (CPET) provides the most direct window. On day 1, ME/CFS patients exercise to maximum capacity and show reduced peak oxygen consumption compared to sedentary controls — but this alone could be deconditioning. On day 2, 24 hours later, healthy controls reproduce their day-1 performance. ME/CFS patients cannot. Their ventilatory threshold drops, their peak VO2 drops, and they cross into anaerobic metabolism at lower workloads (Snell et al. 2013; Stevens et al. 2018). The system is objectively worse after a single bout of maximal exertion. This is the metabolic signature of PEM — post-exertional malaise written in oxygen consumption curves.

The lactate data. ME/CFS patients show elevated venous lactate after exercise at intensities that do not produce significant lactate in controls (Jones et al. 2012). This means they are crossing their anaerobic threshold — the point at which glycolysis outpaces oxidative phosphorylation — at workloads that a healthy person handles aerobically. Walking to the kitchen can exceed the anaerobic threshold. The burning, the exhaustion, the multi-day recovery — these are not imagined symptoms. They are the subjective experience of lactic acidosis at rest-level activity.


3 The math of the cliff

The relationship between mitochondrial damage and ATP output is not linear. A 20% reduction in electron transport chain capacity does not produce a 20% reduction in ATP. The system has reserve capacity — redundant complexes, excess enzyme — that buffers modest damage. But once damage exceeds that buffer, ATP output drops steeply. This is a threshold effect, and it explains one of the most disorienting features of ME/CFS: the cliff.

Patients describe a sharp boundary between “managing” and “collapsed.” They can do some activities — slowly, carefully — and then, without proportional increase in demand, they crash. This is not psychological fragility. It is the nonlinear behaviour of a system operating near its buffering threshold. Small increases in demand that would be invisible in a healthy person push a compromised system past its cliff edge. The math predicts exactly the pattern patients describe.


4 Why the crash is delayed

PEM arrives 12 to 72 hours after exertion, not during it. This delay is the feature that most confuses clinicians trained on peripheral fatigue, where exhaustion is immediate.

Several mechanisms contribute to the delay. Exercise produces reactive oxygen species (ROS) as a byproduct of increased mitochondrial activity. In healthy mitochondria, antioxidant systems neutralise ROS in real time. In damaged mitochondria, ROS production exceeds clearance capacity, and the excess begins damaging the mitochondria themselves — oxidising membrane lipids, damaging mitochondrial DNA, impairing complex function. This damage accumulates during and after exercise but doesn’t manifest as functional impairment until the cell attempts to meet energy demand the following day with now-further-damaged machinery.

Additionally, the inflammatory cascade triggered by exertion — cytokine release, microglial activation, immune cell recruitment — takes 12-24 hours to peak. The subjective crash aligns with the inflammatory peak, not with the mechanical effort.

The cruel result: the patient feels fine during and immediately after exertion. They believe they’re improving. They do more. The crash arrives a day later, teaching nothing about which specific activity caused it, because the temporal coupling between action and consequence is broken.


5 What this is not

This is not “being tired.” Healthy tiredness resolves with rest because the machinery is intact — rest allows ATP pools to refill, glycogen to be replaced, muscle fibres to repair. In ME/CFS, the machinery itself is compromised. Rest reduces demand but does not repair the production system. It is the difference between an empty fuel tank and a damaged engine. Filling the tank doesn’t fix the engine.

This is not deconditioning. Deconditioning reduces aerobic capacity through muscle atrophy and cardiovascular de-training. It is reversed by graduated exercise. ME/CFS is worsened by the same intervention. The 2-day CPET data — deterioration, not improvement, after exertion — directly contradicts the deconditioning hypothesis.

This is not laziness, depression, or lack of willpower. It is measurable, reproducible, cellular-level energy production failure with specific biochemical correlates. No amount of motivation fixes a PDH complex that isn’t working.


6 The scale of the problem

Your body recycles 50 kg of ATP daily. If that recycling rate drops by a third, you lose the energetic equivalent of everything above baseline survival. No vigorous movement. No sustained concentration. No immune surveillance beyond the minimum. No tissue repair beyond emergencies. Everything above keeping you alive gets cut.

That is the energy envelope. Not a metaphor. Not a coping strategy. A metabolic constraint imposed by the output of compromised mitochondria, operating in cells that do their best with machinery that isn’t working properly (Loth 2026).


References

Fluge, Øystein, Olav Mella, Ove Bruland, Kristin Risa, Sissel E Dyrstad, Katarina Alme, Ingrid G Rekeland, et al. 2016. “Metabolic Profiling Indicates Impaired Pyruvate Dehydrogenase Function in Myalgic Encephalopathy/Chronic Fatigue Syndrome.” JCI Insight 1 (21): e89376. https://doi.org/10.1172/jci.insight.89376.
Germain, Arnaud, David Ruppert, Susan M Levine, and Maureen R Hanson. 2017. “Metabolic Profiling of a Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Discovery Cohort Reveals Disturbances in Fatty Acid and Lipid Metabolism.” Mol Biosyst 13 (2): 371–79. https://doi.org/10.1039/c6mb00600k.
Jones, David E. J., Kieren G. Hollingsworth, Djordje G. Jakovljevic, Gulnar Fattakhova, Jessie Pairman, Andrew M. Blamire, Michael I. Trenell, and Julia L. Newton. 2012. “Loss of Capacity to Recover from Acidosis on Repeat Exercise in Chronic Fatigue Syndrome: A Case-Control Study.” European Journal of Clinical Investigation 42 (2): 186–94. https://doi.org/10.1111/j.1365-2362.2011.02567.x.
Loth, Yannick. 2026. “Myalgic Encephalomyelitis / Chronic Fatigue Syndrome: A Comprehensive Medical Documentation.” https://yannickloth.github.io/health-me-cfs/.
Naviaux, Robert K., Jane C. Naviaux, Kefeng Li, A. Taylor Bright, William A. Alaynick, Lin Wang, Asha Baxter, Neil Nathan, Wayne Anderson, and Eric Gordon. 2016. “Metabolic Features of Chronic Fatigue Syndrome.” Proceedings of the National Academy of Sciences 113 (37): E5472–80. https://doi.org/10.1073/pnas.1607571113.
Snell, Christopher R., Staci R. Stevens, Todd E. Davenport, and J. Mark Van Ness. 2013. “Discriminative Validity of Metabolic and Workload Measurements for Identifying People with Chronic Fatigue Syndrome.” Physical Therapy 93 (11): 1484–92. https://doi.org/10.2522/ptj.20110368.
Stevens, Staci, Christopher Snell, Jared Stevens, Betsy Keller, and J. Mark VanNess. 2018. “Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” Frontiers in Pediatrics 6: 242. https://doi.org/10.3389/fped.2018.00242.